Published by Josh White on 12th August 2021
(Sharecast News) - Specialist drug discovery and development company ImmuPharma said on Thursday that the United States Food and Drug Administration (FDA) has approved the start of the pharmacokinetic study as part of its new, "optimised" international phase 3 trial of 'Lupuzor'.
URL: http://www.digitallook.com/dl/news/story/32053364/...